4967.T Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 mai 2024 @ 08:15):

Stats
Dagens volum	1.57M
Gjennomsnittsvolum	2.91M
Markedsverdi	402.92B
EPS	¥0 ( 2024-02-08 )
Neste inntjeningsdato	( ¥0 ) 2024-05-10
Last Dividend	¥39.00 ( 2023-06-29 )
Next Dividend	¥0 ( N/A )
P/E	20.22
ATR14	¥3.49 (0.06%)

Volum Korrelasjon

Lang: 0.32 (neutral)

Kort: 0.24 (neutral)

Signal:(52.238) Neutral

Kobayashi Pharmaceutical Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Kobayashi Pharmaceutical Korrelasjon - Valuta/Råvare

0.28
( neutral )

-0.09
( neutral )

-0.07
( neutral )

-0.77
( moderate negative )

-0.50
( neutral )

Kobayashi Pharmaceutical Økonomi

Annual	2023
Omsetning:	¥173.46B
Bruttogevinst:	¥93.17B (53.72 %)
EPS:	¥268.16

FY	2023
Omsetning:	¥173.46B
Bruttogevinst:	¥93.17B (53.72 %)
EPS:	¥268.16

FY	2022
Omsetning:	¥166.26B
Bruttogevinst:	¥92.33B (55.53 %)
EPS:	¥259.61

FY	2021
Omsetning:	¥155.25B
Bruttogevinst:	¥88.77B (57.18 %)
EPS:	¥187.94

Financial Reports:

No articles found.

Kobayashi Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥0 (N/A)	¥52.00 (N/A)	¥0 (N/A)	¥39.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Kobayashi Pharmaceutical Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.73 - Stable (5.49%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥1.667	2001-03-27
Last Dividend	¥39.00	2023-06-29
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	41	--
Total Paid Out	¥957.83	--
Avg. Dividend % Per Year	0.00%	--
Score	3.7	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.73
Div. Directional Score	7.65	--

Next Divdend (Est)
(2024-06-18)

¥0 Estimate 3.60 %

Dividend Stability

0.29 Very Poor

Dividend Score

3.70

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8136.T	Ex Dividend Knight	2023-09-28	Annually	0.00%
7483.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
6707.T	Ex Dividend Knight	2023-09-28	Annually	0.00%
6058.T	Ex Dividend Junior	2024-02-28	Sporadic	0.00%
4733.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3981.T	Ex Dividend Knight	2023-12-28	Annually	0.00%
3186.T	Ex Dividend Junior	2023-11-29	Annually	0.00%
2180.T	Ex Dividend Junior	2023-12-28	Annually	0.00%
9052.T	Ex Dividend Junior	2023-09-28	Annually	0.00%
7942.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.117	1.500	7.65	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0760	1.200	7.47	8.96	[0 - 0.3]
returnOnEquityTTM	0.0984	1.500	-0.0179	-0.0268	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.82	0.800	0.891	0.713	[1 - 3]
quickRatioTTM	2.37	0.800	0.782	0.625	[0.8 - 2.5]
cashRatioTTM	1.275	1.500	4.03	6.04	[0.2 - 2]
debtRatioTTM	0.00369	-1.500	9.94	-10.00	[0 - 0.6]
interestCoverageTTM	921.00	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	161.45	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	161.45	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.00482	-1.500	9.98	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.545	1.000	4.24	4.24	[0.2 - 0.8]
operatingProfitMarginTTM	0.154	1.000	8.92	8.92	[0.1 - 0.6]
cashFlowToDebtRatioTTM	12.27	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.648	0.800	9.01	7.21	[0.5 - 2]
Total Score				10.57

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	20.42	1.000	8.04	0	[1 - 100]
returnOnEquityTTM	0.0984	2.50	-0.0115	-0.0268	[0.1 - 1.5]
freeCashFlowPerShareTTM	161.45	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	1.824	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	161.45	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	7.10	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0698	1.000	-0.754	0	[0.1 - 0.5]
Total Score				4.73

Kobayashi Pharmaceutical

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. The company provides products in the areas of healthcare, skincare, body warmer, and household. It also offers Ammeltz, a topical analgesic; Inochi no Haha, a women's health medicine; Shirt Coola, a summer cooling spray for cloths; Sarasaty lingerie soap; Bluelet Decoral, a toilet bowl cleaner and freshener; Nightmin Nasal Respiration Tape; Naishitol, a Chinese medicine; Eaude Muge, a medicated lotion for preventing acne; Itoyoji, a dental floss pick; BreathCare, an oral breath freshener capsule; Eybon, an eye wash; Netsusama sheet, a cooling gel sheet for forehead; and Sawaday, a toilet air freshener. Additionally, the company manufactures and sells pharmaceuticals, quasi-drugs, cosmetics, hygiene and paper products, health foods, and processed synthetic resin products; markets nutritional supplements and skin care products through sales promotional campaigns, such as advertising and direct mail; and sells skincare products, health foods, and other items through e-commerce channels. Further, it engages in transportation, real estate management, and advertising planning and production businesses. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.